Market Tracker

04/21 5:16pm ET

Myriad Genetics Inc (NASDAQ:MYGN)

17.61
Delayed Data
As of Apr 21
 -0.14 / -0.79%
Today’s Change
15.15
Today|||52-Week Range
38.10
+5.64%
Year-to-Date

Today’s Trading

Previous close17.75
Today’s open17.75
Day’s range17.55 - 17.84
Volume498,905
Average volume (3 months)1,459,544
Market cap$1.2B
Dividend yield--
Data as of 3:59pm ET, 04/21/2017

Growth & Valuation

Earnings growth (last year)+58.33%
Earnings growth (this year)-39.26%
Earnings growth (next 5 years)-6.60%
Revenue growth (last year)+4.25%
P/E ratio20.5
Price/Sales2.98
Price/Book1.63

Competitors

 Today’s
change
Today’s
% change
QDELQuidel Corp-0.21-0.88%
AAAPAdvanced Accelerator...-0.66-1.75%
--Quidel Corp+0.48+2.26%
ALRPRBAlere Inc-1.38-0.36%
Data as of 3:59pm ET, 04/21/2017

Financials

Next reporting dateMay 9, 2017
EPS forecast (this quarter)$0.23
Annual revenue (last year)$753.8M
Annual profit (last year)$125.3M
Net profit margin16.62%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark C. Capone
Executive Vice President-
International Operations
Gary A. King
Corporate headquarters
Salt Lake City, Utah

Forecasts